Contents
Inflammation & Allergy - Drug Targets (Discontinued), Volume 6 - Number 1
T Lymphocytes as Targets of Statins: Molecular Mechanisms and Therapeutic Perspectives
, 6(1): 3 - 16Raffaella Ghittoni, Pietro Enea Lazzerini, Franco Laghi Pasini and Cosima T. Baldari
DOI: 10.2174/187152807780077291
Highly Selective Phosphodiesterase 4 Inhibitors for the Treatment of Allergic Skin Diseases and Psoriasis
, 6(1): 17 - 26Wolfgang Baumer, Joachim Hoppmann, Chris Rundfeldt and Manfred Kietzmann
DOI: 10.2174/187152807780077318
Vascular Remodelling and Angiogenesis in Asthma: Morphological Aspects and Pharmacological Modulation
, 6(1): 41 - 45Alfredo Chetta, Andrea Zanini, Olga Torre and Dario Olivieri
DOI: 10.2174/187152807780077273
Biological Variability and Targeted Delivery of Therapeutics for Inflammatory Bowel Diseases: An In Silico Approach
, 6(1): 47 - 55Nahor Haddish-Berhane, Ashkan Farhadi, Chell Nyquist, Kamyar Haghighi and Ali Keshavarzian
DOI: 10.2174/187152807780077264
Targeting Kit Activation: A Potential Therapeutic Approach in the Treatment of Allergic Inflammation
, 6(1): 57 - 62Bettina M. Jensen, Dean D. Metcalfe and Alasdair M. Gilfillan
DOI: 10.2174/187152807780077255
Role of Interleukin-21 in Inflammation and Allergy
, 6(1): 63 - 68Daniele Fina, Massimo Claudio Fantini, Francesco Pallone and Giovanni Monteleone
DOI: 10.2174/187152807780077246
Therapeutic Targeting of P-Selectin in Atherosclerosis
, 6(1): 69 - 74Kevin J. Woollard and Jaye Chin-Dusting
DOI: 10.2174/187152807780077345
Webmaster Contact: info@benthamscience.org